Add to Basket
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

CD95 antibody

Antigen

CD95

Clonality Polyclonal
Host
Alternatives

Rabbit

Reactivity
Alternatives

Human

Application
Alternatives Immunohistochemistry (IHC)
3 references available
Catalog no. ABIN97060
Quantity 1ml  (100ug/ml approximately)  (Variants)
Price 523.00 $   Plus shipping costs $35.00
Shipping to
Availability Ships within 5 Business Days

Additional Information

Alternative name CD95 (Fas)
Immunogen A synthetic peptide from the C-terminus of human Fas protein.
Format Ig-fraction, Purified
Specificity This antibody reacts with a 48 kD transmembrane glycoprotein, known as CD95 (Fas). The Fas antigen is expressed on the surface of various cell types, including activated T and B lymphocytes and T lymphoblastoid cell lines. CD95 mediates receptor-triggered apoptosis.

Application Details

Application Notes Titer/Working Dilution: This antibody may be diluted to a titer of 1:25-1:50 in an ABC method. However, depending on the staining conditions employed, we suggest that final dilution should be determined by the user. Staining Protocol: We suggest an incubation period of 30 minutes at room temperature. However, depending upon the fixation conditions and the staining system employed, optimal incubation conditions should be determined by the user. High temperature treatment of formalin-fixed tissue sections with 10mM citrate buffer, pH 6.0 must be performed prior to the immunostaining. Positive Control: Small intestine. Cellular localization: Cell membrane
Concentration 100ug/ml approximately
Buffer Purified immunoglobulin fraction of rabbit antiserum against human CD95 containing sodium azide as preservative.
Storage Store the antibody at 2-8o c. Do not use it beyond the expiration date stated on the label.
Research Area CD Antigens
Restrictions For Research Use. CE-certified for In Vitro Diagnostics (IVD) Use in the European Union

Publications

Publications Kondo, Yoshino, Nishiuchi et al.: "Expression of Fas ligand mRNA in germinal centres of the human tonsil." in: The Journal of pathology, Vol. 183, Issue 1, pp. 75-9, 1997 (PubMed).

Sugihara, Saiki, Tsuji et al.: "Expression of Fas and Fas ligand in the testes and testicular germ cell tumors: an immunohistochemical study." in: Anticancer research, Vol. 17, Issue 5B, pp. 3861-5, 1998 (PubMed).

Sasaki, Ahmed, Takeuchi et al.: "Immunohistochemical study of Fas, Fas ligand and interleukin-1 beta converting enzyme expression in human prostatic cancer." in: British journal of urology, Vol. 81, Issue 6, pp. 852-5, 1998 (PubMed).